Clinical benefit and the Trump administration's cancer medicine reforms

- PMID: 41785891 - DOI: 10.1016/S1470-2045(26)00068-9

Clinical benefit and the Trump administration's cancer medicine reforms

No abstract available

Conflict of interest statement

TJH has received grants from the Swiss Cancer Research Foundation and Kaiser Permanente Institute for Health Policy and serves as a member of the ESMO Working Group on the Magnitude of Clinical Benefit Scale. KNV has received grants from the Swiss Cancer Research Foundation and the Swiss National Science Foundation and serves as a member of the ESMO Cancer Medicines Committee. This Comment does not represent the official positions of ESMO or the authors' funders, which had no involvement in the preparation of this Comment or the decision to submit it for publication.

LinkOut - more resources

Full Text Sources